Molecular formula: | C18H18ClIN6O4 |
Average mass: | 544.734 |
Monoisotopic mass: | 544.012279 |
ChemSpider ID: | 2299989 |
4 of 4 defined stereocentres
(2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide
(2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide
(2S,3S,4R,5R)-5-{2-Chlor-6-[(3-iodbenzyl)amino]-9H-purin-9-yl}-3,4-dihydroxy-N-methyltetrahydro-2-furancarboxamid (non-preferred name)
[German]
[ACD/IUPAC Name](2S,3S,4R,5R)-5-{2-Chloro-6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-3,4-dihydroxy-N-methyltetrahydro-2-furancarboxamide (non-preferred name)
[ACD/IUPAC Name](2S,3S,4R,5R)-5-{2-Chloro-6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-3,4-dihydroxy-N-méthyltétrahydro-2-furanecarboxamide (non-preferred name)
[French]
[ACD/IUPAC Name]163042-96-4
[RN]2-Chloro-N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide
2-Cl-IB-MECA
Chloro-IB-MECA
Cl-IB-MECA
MFCD01861178
[MDL number]namodenoson
[INN] [USAN]namodenosón
[Spanish]
[INN]namodénoson
[French]
[INN]namodenosonum
[Latin]
[INN]Z07JR07J6C
[UNII]намоденозон
[Russian]
[INN]نامودينوسون
[Arabic]
[INN](2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide
(2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-2-chloro-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide
(2S,3S,4R,5R)-5-[2-Chloro-6-(3-iodo-benzylamino)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-carboxylic acid methylamide
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodobenzyl)amino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]-9-purinyl]-3,4-dihydroxy-N-methyl-2-tetrahydrofurancarboxamide
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-β-D-Ribofuranuronamide
1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-D-ribofuranuronamide
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-β-D-RIBOFURANURONAMIDE
2-Chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-β-D-ribofuranosyl)adenine
2-Chloro-N(6)-(3-iodobenzyl)adenosine-5′-N-methyluronamide
2-chloro-N6-(3-iodobenzyl)-5′-N-methylcarboxamidoadenosine
2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide
2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide
2Cl-IB-MECA
5-[2-Chloro-6-(3-iodo-benzylamino)-purin-9-yl]-3,4-dihydroxy-tetrahydro-furan-2-carboxylic acid methylamide
5-hydroxytryptamine receptor 2A
5-hydroxytryptamine receptor 2B
5-hydroxytryptamine receptor 2C
5HT2A_HUMAN
5HT2B_HUMAN
5HT2C_HUMAN
95%
AA1R_CHICK
AA1R_HUMAN
AA2AR_HUMAN
AA3R_HUMAN
ABCG2_HUMAN
Adenosine A₃
Adenosine receptor A1
Adenosine receptor A2a
Adenosine receptor A3
C-Ibza-μ
cf-102(2-cl-ib-meca)
namodénoson
namodenosón
namodenosonum
PPARD_HUMAN
PPARG_HUMAN
β-D-Ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-
намоденозон
نامودينوسون
那莫诺生
[Chinese]